Skip to main content
BrainCited

Omega-3 Fatty Acids (DHA/EPA) para Cerebrovascular Health

B

DHA supports vascular endothelial function and may help reduce neuroinflammation. In CAD patients, 3.36 g/day supplementation was associated with slowed cognitive aging equivalent to approximately 2.5 years.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dcerebrovascular\u002Dhealth'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Conclusión

DHA supports vascular endothelial function and may help reduce neuroinflammation. In CAD patients, 3.36 g/day supplementation was associated with slowed cognitive aging equivalent to approximately 2.5 years.

Key Study Findings

Review
The Clinical Implications of Ashwagandha (Withania somnifera L.) with a Special Reference to Side Effects-A …
Dose: None vs: None Outcome: None Efecto: None None

Población: narrative review of ashwagandha clinical trials and basic research (1994-present)

Other 10 weeks
Ginkgo biloba Extract GBE50 ameliorates cerebrovascular dysfunction and cognitive impairment in a mouse model of …
Dose: None vs: Untreated APP/PS1 mice Outcome: Cognitive performance in behavioral tests Efecto: None None

Población: APP/PS1 transgenic Alzheimer's disease mouse model

Review
Herbal Medicines in Autism Spectrum Disorder: Therapeutic Potential, Plant Components, and Dosage Guidelines.
Dose: None vs: None Outcome: ASD symptom management Efecto: None None

Población: Children with autism spectrum disorder

Cohort Study n=215624
Neuroticism, omega-3 fatty acids, and risk of incident dementia.
Dose: None vs: None Outcome: Incident all-cause dementia Efecto: None <0.05 (Bonferroni)

Población: Dementia-free UK Biobank participants aged 40-69

preclinical animal/in vitro study
Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice …
Dose: 60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL vs: Placebo Efecto: None None
Other 26 weeks
Systems biology modelling based evaluation of omega-3 formulation in managing cardiovascular and cerebrovascular risk.
Dose: EPA 180mg + DHA 120mg vs: Simulated disease population baseline Outcome: Lipid biomarker changes (in silico model) Efecto: 14.7% TG reduction, 22.38% HDL increase None

Población: Simulated CVD disease population (in silico study)

Key Statistics

12

Estudios

2000

Participantes

Positive

B

Calificación

Referenced Papers

Nutrients 2025 2 citas
Acta pharmaceutica Sinica. … 2024 33 citas
La Revue du … 2024
Nature reviews. Disease … 2021 163 citas
The Senior care … 2021 2 citas
Journal of ethnopharmacology 2020 85 citas
Current neurology and … 2019 11 citas
Current treatment options … 2017 56 citas
Journal of psychosocial … 2011 26 citas
Journal of Alzheimer's … 2010 110 citas
The Practitioner 2010
The Cochrane database … 2003 263 citas
The Medical clinics … 2002 59 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:
1,000-2,000 mg combined DHA/EPA per day
cognitivesupport:
1,000-1,700 mg/day (optimal dose-response curve)

Límite superior: 3,000 mg/day combined DHA/EPA (FDA GRAS)

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
None -- Positive --
None 10 weeks Positive --
None -- Positive --
None -- Positive 215624
60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL -- Positive --
EPA 180mg + DHA 120mg 26 weeks Positive --
None -- Mixed --
None -- Mixed --

Mejor momento para tomar: With meals containing fat for better absorption

Safety & Side Effects

Efectos secundarios reportados

  • Fishy aftertaste or burping
  • Mild gastrointestinal discomfort
  • Potential increased bleeding time at very high doses
  • May lower blood pressure slightly

Interacciones conocidas

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (may reduce omega-3 absorption)

Ingesta máxima tolerable: 3,000 mg/day combined DHA/EPA (FDA GRAS)

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Omega-3 Fatty Acids (DHA/EPA) help with Cerebrovascular Health?
Based on 12 studies with 2,000 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (DHA/EPA) may support Cerebrovascular Health management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Cerebrovascular Health?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Cerebrovascular Health?
We rate the evidence as Grade B (Good Evidence). This rating is based on 12 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.